{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Solriamfetol+300+mg", "query": { "intervention": "Solriamfetol 300 mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 12, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Solriamfetol+300+mg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-24T01:29:20.646Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02348619", "title": "\"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obstructive Sleep Apnea" ], "interventions": [ { "name": "JZP-110", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 174, "start_date": "2015-05", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2019-09-09", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Oceanside, California • Orange, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Oceanside", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Lakewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02348619" }, { "nct_id": "NCT06413433", "title": "Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Binge-Eating Disorder" ], "interventions": [ { "name": "Solriamfetol 150 mg", "type": "DRUG" }, { "name": "Solriamfetol 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 450, "start_date": "2024-04-26", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 44, "location_summary": "Encino, California • Garden Grove, California • Long Beach, California + 38 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06413433" }, { "nct_id": "NCT03037203", "title": "A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Excessive Sleepiness", "Parkinson Disease" ], "interventions": [ { "name": "JZP-110", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "35 Years to 80 Years" }, "enrollment_count": 66, "start_date": "2017-01", "completion_date": "2018-08", "has_results": true, "last_update_posted_date": "2020-01-09", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 25, "location_summary": "Los Angeles, California • San Diego, California • Boulder, Colorado + 22 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03037203" }, { "nct_id": "NCT01681121", "title": "A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy" ], "interventions": [ { "name": "ADX-N05", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 93, "start_date": "2012-09", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2021-05-28", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Redwood City, California + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Redwood City", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01681121" }, { "nct_id": "NCT02348593", "title": "\"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Narcolepsy" ], "interventions": [ { "name": "JZP-110", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 239, "start_date": "2015-05", "completion_date": "2017-02", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 45, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Scottsdale, Arizona + 38 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02348593" }, { "nct_id": "NCT01485770", "title": "A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy" ], "interventions": [ { "name": "ADX-N05", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 33, "start_date": "2011-12", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2021-07-06", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 10, "location_summary": "Phoenix, Arizona • St. Petersburg, Florida • Atlanta, Georgia + 6 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Macon", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01485770" }, { "nct_id": "NCT06360419", "title": "Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Solriamfetol 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 346, "start_date": "2024-03-18", "completion_date": "2025-03-26", "has_results": false, "last_update_posted_date": "2026-01-05", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 40, "location_summary": "Little Rock, Arkansas • Bellflower, California • Encino, California + 35 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06360419" }, { "nct_id": "NCT05972044", "title": "A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "ADHD" ], "interventions": [ { "name": "Solriamfetol 150 mg", "type": "DRUG" }, { "name": "Solriamfetol 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 516, "start_date": "2023-07-06", "completion_date": "2025-03-14", "has_results": false, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 42, "location_summary": "Encino, California • Garden Grove, California • Newport Beach, California + 37 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05972044" }, { "nct_id": "NCT02348606", "title": "\"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obstructive Sleep Apnea" ], "interventions": [ { "name": "JZP-110", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 476, "start_date": "2015-05", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 45, "location_summary": "Glendale, Arizona • Scottsdale, Arizona • Little Rock, Arkansas + 38 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02348606" }, { "nct_id": "NCT06568367", "title": "Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Excessive Sleepiness", "Shift-work Disorder" ], "interventions": [ { "name": "Solriamfetol 150 mg", "type": "DRUG" }, { "name": "Solriamfetol 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 520, "start_date": "2024-08-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-24T01:29:20.646Z", "location_count": 44, "location_summary": "Auburn, Alabama • Cullman, Alabama • Chandler, Arizona + 37 more", "locations": [ { "city": "Auburn", "state": "Alabama" }, { "city": "Cullman", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06568367" } ] }